Do peptides help with muscle recovery and injury?
4 peptides are graded for muscle recovery and injury on this page. The strongest grade is animal-only evidence, for BPC-157, TB-500 (thymosin beta-4), PEG-MGF, and IGF-1 LR3. Each one is weighed against the standard of care below, and the evidence table gives the grade and a note for every peptide.
What is the standard of care for muscle recovery and injury?
Relative rest, early controlled loading, physical therapy, adequate protein intake, and sleep. Surgery for complete tears of major muscles or tendons.
Any peptide below should be judged against this baseline, not against doing nothing. Talk to a licensed provider before replacing or adding to an established treatment.
Which peptides have been studied for muscle recovery and injury?
Ordered by strength of evidence for this use. Grades follow the methodology; each peptide page lists the individual studies.
| Peptide | Evidence for this use | Note |
|---|---|---|
| BPC-157 | Evidence: Animal-only evidence | Faster healing of transected and crushed muscle in rats; no human trial. [1] [2] |
| TB-500 (thymosin beta-4) | Evidence: Animal-only evidence | Cell migration and anti-inflammatory effects in animal models; no human trial for muscle injury. [2] |
| PEG-MGF | Evidence: Animal-only evidence | Mechano growth factor splice variant; rodent and cell data only; WADA prohibited. [2] |
| IGF-1 LR3 | Evidence: Animal-only evidence | Long acting IGF-1 analog used in cell culture; no human clinical trials; WADA prohibited. [2] |
Head-to-head comparisons
Cost and access
Price ranges, lawful channels, and insurance notes for peptides graded here. State rules are in the legal guides by state.
Frequently asked questions
Which peptide has the strongest evidence for muscle recovery and injury?
BPC-157, TB-500 (thymosin beta-4), PEG-MGF, and IGF-1 LR3 have the strongest evidence among the peptides graded here, at animal only evidence. BPC-157: Faster healing of transected and crushed muscle in rats; no human trial. TB-500 (thymosin beta-4): Cell migration and anti-inflammatory effects in animal models; no human trial for muscle injury. PEG-MGF: Mechano growth factor splice variant; rodent and cell data only; WADA prohibited. IGF-1 LR3: Long acting IGF-1 analog used in cell culture; no human clinical trials; WADA prohibited. No peptide graded for this use has a randomized human trial. [1] [2]
Is any peptide FDA approved for muscle recovery and injury?
No. None of the peptides graded for muscle recovery and injury is an FDA approved drug, so any use is outside an approved label and depends on the compounding and research status shown on each peptide page. [3]
Has any peptide been tested in a randomized trial for muscle recovery and injury?
No. The best evidence for any peptide graded for muscle recovery and injury is animal only evidence, so none has been shown to work in a randomized human trial for this use. [1] [2]
From the blog
- BPC-157 before and after: reviews, results, and what controlled studies show
BPC-157 reviews and before and after stories are everywhere. Controlled results exist only in rats. What the animal healing timelines show, what the human pilots found, and why anecdotes mislead.
- Does tesamorelin build muscle? What the trials show
Tesamorelin raised lean body mass about 1.2 kg in HIV trials and slightly increased trunk muscle area, but no trial tested strength or muscle growth, and it is prohibited in sport.
- Peptide stacks: what each common component has shown alone
No trial has tested a multi-peptide stack for muscle growth or fat loss. Nine common stack components ranked by their own human evidence, legal status, and WADA status. No protocols.
- Peptides for muscle growth, ranked by human evidence
MK-677, sermorelin, tesamorelin, CJC-1295, IGF-1 LR3, and more ranked by human evidence. None is approved for muscle growth, and all ten are banned in tested sport.
Sources
- [1]BPC 157 and its role in accelerating musculoskeletal soft tissue healing (Cell Tissue Res 2019)PubMed 30915550, 2019
- [2]WADA Prohibited ListWADA, 2026
- [3]Drugs@FDA: FDA-approved drugs databaseFDA